Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway (Q38722609)

5 September 2017

title

Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway (English)

1 reference

head and neck squamous cell carcinoma

5 September 2017

main subject

1 reference

Chao Ma

1 reference

5 September 2017

Jianqi Wang

series ordinal

1 reference

5 September 2017

Longkun Fan

series ordinal

1 reference

5 September 2017

Yanjun Guo

series ordinal

1 reference

5 September 2017

publication date

3 January 2017

1 reference

Experimental and Molecular Pathology

5 September 2017

published in

1 reference

5 September 2017

volume

102

1 reference

5 September 2017

1 reference

5 September 2017

page(s)

59-64

1 reference

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Current trends and future perspectives in the surgical management of oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

7 January 2021

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Resistance to cisplatin-induced cell death conferred by the activity of organic anion transporting polypeptides (OATP) in human melanoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Current concepts for the management of head and neck cancer: chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Global cancer statistics, 2012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

The protein kinase C family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2017.01.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXMP.2017.01.002

1 reference

5 September 2017

1 reference